Hemostasis Valves Market

Stakeholders Innovate on Hemostasis Valves for Future Therapeutic Catheter Development Projects

Hemostasis valves aid healthcare providers in delivering efficiency in next-generation catheter and delivery systems. Stakeholders in the hemostasis valves market are increasing research and development to offer innovative devices with new designs that cater to consumer needs and are easily adjustable.

Likewise, minimally-invasive technologies in hemostasis valves facilitate improved procedural workflow and enhanced tactile feel and control. This technology ensures the prolonged durability of hemostasis valves, and maintains the hemostasis even after multiple or large catheter insertions. As such, stakeholders are developing value-added features such as single user and single handed operations for hemostasis valves.

To leverage the use of minimally-invasive hemostasis valves in catheter systems, manufacturers are developing valve assemblies that easily integrate into the catheter and delivery system. Thus, innovations in hemostasis valves can be integrated for future therapeutic catheter development projects to give rise to new design options and shorten the development time. For instance, in May 2019, Merit Medical Systems Inc. - a global leader in the medical device industry, announced the launch of the PhD™ (Push, Hold, Deliver) polycarbonate hemostasis valve, which allows doctors and healthcare providers to operate the valve with one hand during insertion and withdrawal of diagnostic or interventional devices.

To know the scope of our report Get a Sample on Hemostasis Valves Market 

Advances in Device Designs Trigger Applications in Endovascular Treatment

Ongoing research and development is being carried out by manufacturers to develop robust hemostasis valves that provide efficient vascular access applications. New designs in catheter-supported hemostasis valves are being developed to try to overcome unique challenges in trans-catheter valves and the endovascular landscape, such as large perforate vascular access and delivery systems. Thus, the increasing size of emerging therapeutic devices is leading to innovations and novel solutions to reduce risk and improve outcomes through high-end catheter-supported hemostasis valves.

As such, stakeholders are collaborating with research experts to brainstorm on the unmet clinical needs and offer healthcare providers with a growing portfolio of cutting-edge hemostasis valves with improved device designs. For instance, Freudenberg Medical, LLC - a leading manufacturer of medical devices, announced the launch of Composer® XL and HyperSeal® XL, to address the challenges of large perforate vascular access and device delivery in trans-catheter valve and endovascular applications.

Get a glimpse of the in-depth analysis through our Report Brochure?

Manufacturers Overcome Functional Limitations by Increasing Offerings in Existing Products

Although the hemostasis valves ecosystem has seen tremendous developments in transforming the way valves function, there are certain limitations in specialized treatments. Since a hemostasis valve is a component of the microcatheter facilitated reverse wire technique to operate bifurcated lesions, it is challenging for healthcare providers to treat percutaneous coronary intervention, especially with severe proximal stenosis. However, it is suggested that, the crusade microcatheter facilitated reverse wise technique with short tip one curve is an efficient and safe way of wiring in solving angulated bifurcated lesions.

Apart from innovations in hemostasis valves, manufacturers are developing dual valve adapters designed to function with sheath introducers. With the help of two separate valves, doctors can operate and control multiple devices while maintaining a secure seal that stops leaks. Dual valve adapters fix perfectly on the sheath cap to avoid leaks during interventions, and are compatible with multiple sized devices.

Expanding operations in future? To get the perfect launch ask for a custom report 

Analysts’ Viewpoint

Analysts of the hemostasis valves market have a positive outlook for the growth of the market during the forecast period of 2019-2027. Ongoing research and developments are being made to increase offerings in minimally-invasive technologies for hemostasis valves in catheter systems. The emergence of new cath labs in North America, Europe, and Asia Pacific are anticipated to increase the demand for hemostasis valves in high-end catheter systems. However, the functional limitations of hemostasis valves in the microcatheter-facilitated reverse wire technique for specialized treatments still pose as a restraint. As such, stakeholders are innovating in double valve and Y connector products in the hemostasis valves ecocystem.